By continuing to use this site, you agree to our use of cookies as described in our Cookie Policy.
Menu
By continuing to use this site, you agree to our use of cookies as described in our Cookie Policy.
SUPPORT & RESOURCES
Download helpful educational materials to learn more about CREXONT
SUPPORT
RESOURCES
Eligible commercially insured patients may qualify for a $25 copay on their prescriptions, applied automatically for most patients at the pharmacy through the CREXONT Savings Program.*†‡
RESOURCES
Download our comprehensive brochure to see essential details about CREXONT. Learn how this extended-release capsule with personalized dosing works to help provide more “Good On” time* compared to IR CD/LD.
NEWSLETTER
Access the thrive newsletters: A series solely focused on subjects that affect people living with Parkinson’s and their care partners. These newsletters cover a wide range of topics, from the benefits of cycling, boxing, and music therapy to the power of perseverance and hope in managing Parkinson’s disease.
SUPPORT
Find a local chapter for help and support through the American Parkinson Disease Association
Discover helpful Parkinson’s resources, events, research, and more with the Davis Phinney Foundation
Access resources and find local events geared towards those with Parkinson’s through the Parkinson & Movement Disorder Alliance
Explore the latest research and important information about Parkinson’s with the Michael J. Fox Foundation for Parkinson’s Research
The Parkinson Council offers events, support groups, and activities for individuals with Parkinson’s and their care partners
The Parkinson’s Foundation features helpful resources ranging from local events to hospital safety guidelines to a comprehensive PD library to access any the information you may need
Footnotes
*“Good On” time is defined as “On” time without troublesome dyskinesia.
*Maximum benefit of $150.
†The CREXONT Co-Pay Savings Program is not valid for prescriptions submitted for reimbursement to Medicare, Medicaid, other federal or state programs (including any state pharmaceutical assistance programs), or private indemnity or HMO insurance plans that reimburse you for the entire cost of your prescription drugs. This program is good for use only with a CREXONT prescription at the time the prescription is filled by the pharmacist and dispensed to the patient. Offer good only in the USA at participating retail pharmacies. Void if prohibited by law, taxed, or restricted. Amneal reserves the right to rescind, revoke, or amend this offer at any time without notice. By participating in this program, you acknowledge that you are an eligible patient and that you understand and agree to comply with the terms and conditions of this offer.
‡Subject to eligibility requirements.
CREXONT® (carbidopa and levodopa) extended-release capsules is a prescription medication for the treatment of Parkinson’s disease, Parkinson’s disease caused by infection or inflammation of the brain, or Parkinson’s disease-like symptoms that may result from carbon monoxide or manganese poisoning in adults.
Do not take CREXONT with antidepressant medications known as nonselective monoamine oxidase (MAO) inhibitors.
Do not take CREXONT with other carbidopa-levodopa preparations without consulting your healthcare provider.
CREXONT may cause falling asleep during activities of daily living, somnolence, or dizziness. Avoid activities that require alertness such as driving and operating machinery until you know how CREXONT affects you.
The most common side effects that may occur with CREXONT are nausea and anxiety.
It is important to avoid sudden discontinuation or rapid dose reduction of CREXONT. If you are discontinuing CREXONT, work with your healthcare provider to taper the dose over time to reduce the risk of fever or confusion.
You may take CREXONT with or without food, but taking it with food may decrease or delay its effect. Consider taking the first dose of the day about 1 to 2 hours before eating.
Swallow CREXONT whole. Do not chew, divide, or crush the capsules.
Do not take CREXONT with alcohol.
Tell your healthcare provider if you:
CREXONT® (carbidopa and levodopa) extended-release capsules is a prescription medication for the treatment of Parkinson’s disease, Parkinson’s disease caused by infection or inflammation of the brain, or Parkinson’s disease-like symptoms that may result from carbon monoxide or manganese poisoning in adults.
To report SUSPECTED ADVERSE REACTIONS, contact Amneal Specialty, a division of Amneal Pharmaceuticals, LLC at 1-877-835-5472 or the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Please read the full Prescribing Information. For more information talk to your healthcare provider.
CREXONT® (carbidopa and levodopa) extended-release capsules is a prescription medication for the treatment of Parkinson’s disease, Parkinson’s disease caused by infection or inflammation of the brain, or Parkinson’s disease-like symptoms that may result from carbon monoxide or manganese poisoning in adults.
Do not take CREXONT with antidepressant medications known as nonselective monoamine oxidase (MAO) inhibitors.
Do not take CREXONT with other carbidopa-levodopa preparations without consulting your healthcare provider.
CREXONT may cause falling asleep during activities of daily living, somnolence, or dizziness. Avoid activities that require alertness such as driving and operating machinery until you know how CREXONT affects you.
The most common side effects that may occur with CREXONT are nausea and anxiety.
It is important to avoid sudden discontinuation or rapid dose reduction of CREXONT. If you are discontinuing CREXONT, work with your healthcare provider to taper the dose over time to reduce the risk of fever or confusion.
You may take CREXONT with or without food, but taking it with food may decrease or delay its effect. Consider taking the first dose of the day about 1 to 2 hours before eating.
Swallow CREXONT whole. Do not chew, divide, or crush the capsules.
Do not take CREXONT with alcohol.
Tell your healthcare provider if you:
CREXONT® (carbidopa and levodopa) extended-release capsules is a prescription medication for the treatment of Parkinson’s disease, Parkinson’s disease caused by infection or inflammation of the brain, or Parkinson’s disease-like symptoms that may result from carbon monoxide or manganese poisoning in adults.
To report SUSPECTED ADVERSE REACTIONS, contact Amneal Specialty, a division of Amneal Pharmaceuticals, LLC at 1-877-835-5472 or the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Please read the full Prescribing Information. For more information talk to your healthcare provider.
CREXONT® is a registered trademark of Amneal Pharmaceuticals LLC. © 2024 Amneal Pharmaceuticals LLC.
Distributed by Amneal Specialty, a division of Amneal Pharmaceuticals LLC.
All rights reserved. PP-IPX203-US-0026 08/2024
This is intended for residents of the United States only. Any product discussed herein may have different product labeling in different countries. Please read the full Prescribing Information and discuss it with your doctor or healthcare professional.
